Clinical trial
Iressa Follow-up Trial
NCT00357734 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00357734 |
|---|---|
| Title | Iressa Follow-up Trial |
| Official title | Multicenter Open-label, Long-term Safety Trial of Treatment Extension With ZD1839 in Patients Who Have Been Treated in Other ZD1839 Clinical Trials. |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lung Cancer, Breast Cancer |
| Intervention type | Drug |
| Interventions | Gefitinib |
| Enrollment | 14 |
| Start date | Jan 1, 2005 |
| Primary completion | May 1, 2015 |
| Completion | May 1, 2015 |
| First posted | Jul 27, 2006 |
| Last update posted | Aug 30, 2016 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: